A clinical study on Karisalai mathirai for Pitha paandu (Iron deficiency Anaemia)

A prospective open labelled , Non-randomized ,phase II clinical trial of Karisalai mathirai in the management of Pitha paandu (Iron deficiency Anaemia)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019214

Enrollment

Registered

2019-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: KARISALAI MATHIRAI: 1-2 Tablet BD A/F along With Butter Milk for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hb level between 7.1 - 10 grams 2. Pallor of skin , mucous membrane, conjuctiva, nailbeds 3. Fatigue, shortness of breath, palpitation 4. Anorexia 5.Blood loss due to menstrual disorders,hemorrhoids and peptic ulcer

Exclusion criteria

Exclusion criteria: 1. Congenital heart disease 2. Patients with chronic renal disease 3. Liver disease 4.Inherited hemolytic defects 5.Thalassemia 6. Thyroid disease 7.Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
1. Relief of clinical symptoms mentioned in inclusion criteria 2. Increase in HB level 3. Improvement in lab parametersTimepoint: 45 days	—

Secondary

Measure	Time frame
1. Evaluation of heamatinic activity of trial drug 2. Evaluation of additional effects and changes of siddha parameters in Pitha Paandu 3.Evaluation of safety profile, Biochemical and pharmacological parameters of trial drug.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr G SubashChandran MD PhD

Govt Siddha Medical college and hospital Palayamkottai Tirunelveli

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026